tiprankstipranks
NexgenRx Inc (TSE:NXG)
TSXV:NXG
Canadian Market
Holding TSE:NXG?
Track your performance easily

NexgenRx (NXG) Financial Statements

11 Followers

NexgenRx Financial Overview

NexgenRx's market cap is currently ―. The company's EPS TTM is C$0; its P/E ratio is -707.50; and it has a dividend yield of 3.45%. NexgenRx is scheduled to report earnings on April 9, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total RevenueC$ 4.08MC$ 4.29MC$ 3.57MC$ 3.39MC$ 3.42M
Gross ProfitC$ 3.18MC$ 3.40MC$ 2.75MC$ 2.66MC$ 2.67M
EBITC$ 84.60KC$ 479.53KC$ -162.88KC$ -146.01KC$ 8.46K
EBITDAC$ 406.79KC$ 798.33KC$ 155.76KC$ 176.03KC$ 344.93K
Net Income Common StockholdersC$ 31.92KC$ 460.95KC$ -387.58KC$ -130.73KC$ -8.59K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 1.81MC$ 1.36MC$ 1.88MC$ 1.94MC$ 1.27M
Total AssetsC$ 30.63MC$ 29.29MC$ 30.20MC$ 29.44MC$ 28.85M
Total DebtC$ 487.94KC$ 447.65KC$ 461.88KC$ 399.28KC$ 410.48K
Net DebtC$ -1.32MC$ -913.37KC$ -1.41MC$ -1.54MC$ -859.15K
Total LiabilitiesC$ 22.71MC$ 21.01MC$ 22.48MC$ 20.93MC$ 20.25M
Stockholders EquityC$ 7.92MC$ 8.27MC$ 7.71MC$ 8.51MC$ 8.60M
Cash Flow-
Free Cash FlowC$ 853.55KC$ -544.95KC$ 385.49KC$ 655.41KC$ 440.29K
Operating Cash FlowC$ 986.17KC$ -526.46KC$ 397.36KC$ 708.69KC$ 617.24K
Investing Cash FlowC$ -158.92KC$ -60.55KC$ -11.87KC$ -53.28KC$ -176.95K
Financing Cash FlowC$ -378.72KC$ 71.27KC$ -445.96KC$ 12.21KC$ -435.00K
Currency in CAD

NexgenRx Earnings and Revenue History

NexgenRx Debt to Assets

NexgenRx Cash Flow

NexgenRx Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis